<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; events</title>
	<atom:link href="http://www.tapanray.in/tag/events/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>India’s Drug Quality Concerns: Is Light At The End of The Tunnel In Sight Now?</title>
		<link>http://www.tapanray.in/indias-drug-quality-concerns-is-light-at-the-end-of-the-tunnel-in-sight-now/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indias-drug-quality-concerns-is-light-at-the-end-of-the-tunnel-in-sight-now</link>
		<comments>http://www.tapanray.in/indias-drug-quality-concerns-is-light-at-the-end-of-the-tunnel-in-sight-now/#comments</comments>
		<pubDate>Mon, 07 Aug 2023 00:00:43 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[action]]></category>
		<category><![CDATA[big]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[end]]></category>
		<category><![CDATA[events]]></category>
		<category><![CDATA[GMP]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[light]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[QR]]></category>
		<category><![CDATA[Quality]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regulators]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[Saga]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tunnel]]></category>
		<category><![CDATA[two=pronged]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10805</guid>
		<description><![CDATA[A brief chronology of some recent events on issues pertaining to patient-health-safety with drugs, as captured below, would possibly generate a mixed feeling for many. This includes a serious concern about, especially generic drug quality safety standards in India, on the one &#8230; <a href="http://www.tapanray.in/indias-drug-quality-concerns-is-light-at-the-end-of-the-tunnel-in-sight-now/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indias-drug-quality-concerns-is-light-at-the-end-of-the-tunnel-in-sight-now/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Time To Audit Pharma’s Doctor-Engagement And Other Digital Strategies</title>
		<link>http://www.tapanray.in/time-to-audit-pharmas-doctor-engagement-and-other-digital-strategies/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=time-to-audit-pharmas-doctor-engagement-and-other-digital-strategies</link>
		<comments>http://www.tapanray.in/time-to-audit-pharmas-doctor-engagement-and-other-digital-strategies/#comments</comments>
		<pubDate>Mon, 25 Jan 2021 00:00:20 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[audit]]></category>
		<category><![CDATA[channel]]></category>
		<category><![CDATA[content]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[e-marketing]]></category>
		<category><![CDATA[e-visits]]></category>
		<category><![CDATA[engagement]]></category>
		<category><![CDATA[events]]></category>
		<category><![CDATA[format]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Information]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Patient-Centricity]]></category>
		<category><![CDATA[physical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reps]]></category>
		<category><![CDATA[strategies]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[value-delivery]]></category>
		<category><![CDATA[walk the talk]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10400</guid>
		<description><![CDATA[It’s now over a year since the unprecedented global health crisis commenced. In this grueling saga, a silver lining is also visible. It helped pharma industry gain a fascinating operational experience, while navigating through disruptive business changes. The changes in the &#8230; <a href="http://www.tapanray.in/time-to-audit-pharmas-doctor-engagement-and-other-digital-strategies/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/time-to-audit-pharmas-doctor-engagement-and-other-digital-strategies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Marketing Off-label Use of Drugs: A Path Much Abused?</title>
		<link>http://www.tapanray.in/marketing-off-label-use-of-drugs-a-path-much-abused/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=marketing-off-label-use-of-drugs-a-path-much-abused</link>
		<comments>http://www.tapanray.in/marketing-off-label-use-of-drugs-a-path-much-abused/#comments</comments>
		<pubDate>Mon, 30 Nov 2015 00:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[abused]]></category>
		<category><![CDATA[ADE]]></category>
		<category><![CDATA[adverse]]></category>
		<category><![CDATA[cities]]></category>
		<category><![CDATA[common]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[electronic]]></category>
		<category><![CDATA[events]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Internal]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[JAMA]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[methods]]></category>
		<category><![CDATA[off-label]]></category>
		<category><![CDATA[opposes]]></category>
		<category><![CDATA[path]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[records]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[smart]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[usages]]></category>
		<category><![CDATA[use]]></category>
		<category><![CDATA[USFDA]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7296</guid>
		<description><![CDATA[As many would know, prescribing any medicine for disease conditions that are not approved by the drug approving authorities while granting its marketing approval, is generally termed as ‘off-label’ use of drugs. It is also a usual practice in most &#8230; <a href="http://www.tapanray.in/marketing-off-label-use-of-drugs-a-path-much-abused/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/marketing-off-label-use-of-drugs-a-path-much-abused/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The stormy debate on wrongful grant of pharma product patents – a countdown of the news events, for a quick perspective.</title>
		<link>http://www.tapanray.in/the-stormy-debate-on-wrongful-grant-of-pharma-product-patents-a-countdown-of-the-news-events-for-a-quick-perspective/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-stormy-debate-on-wrongful-grant-of-pharma-product-patents-a-countdown-of-the-news-events-for-a-quick-perspective</link>
		<comments>http://www.tapanray.in/the-stormy-debate-on-wrongful-grant-of-pharma-product-patents-a-countdown-of-the-news-events-for-a-quick-perspective/#comments</comments>
		<pubDate>Thu, 12 Mar 2009 16:55:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[3.d]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[countdown]]></category>
		<category><![CDATA[debate]]></category>
		<category><![CDATA[events]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Grant]]></category>
		<category><![CDATA[incremental]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[news]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[perspective]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Quick]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[section]]></category>
		<category><![CDATA[Stormy]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[wrongful]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=944</guid>
		<description><![CDATA[To give a quick perspective to this debate, I reckon, a countdown of five reported news events on the subject will be helpful. I start from February, 2009 and gradually go one year back, to February, 2008, to capture the &#8230; <a href="http://www.tapanray.in/the-stormy-debate-on-wrongful-grant-of-pharma-product-patents-a-countdown-of-the-news-events-for-a-quick-perspective/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-stormy-debate-on-wrongful-grant-of-pharma-product-patents-a-countdown-of-the-news-events-for-a-quick-perspective/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
